View Full Team

Terry
Gould

Partner & Head of Venture Growth Investments

Terry is a Partner and Head of Venture Growth Equity Investments. He invests in venture and growth-oriented companies with a focus on the healthcare space. Terry sits on the Boards of Directors of Aptinyx, Corvus, LifeBond, OncoMed (NADSAQ: OMED), Orbus Pharmaceuticals, and Outpost Medicine. He is a former board member at CombiChem, INC Research, Incline Therapeutics, and Proteus Digital Health. Terry is also a member of the Adams Street Executive and Direct Investment Committees.

Terry's past investments include:

  • Heartport (bought by Johnson and Johnson)
  • Jazz Pharmaceuticals (NASDAQ: JAZZ)
  • Naurex Pharmaceuticals
  • NxStage Medical
  • Pharmacyclics (NASDAQ: PCYC)
  • Rempex Pharmaceuticals (bought by the Medicines Company)
  • Revivant (bought by Zoll)
  • Spinal Dynamics (bought by Medtronic)
  • Vivant Medical (bought by Tyco International Ltd.)

Previous Experience
Brinson Partners/UBS Global Asset Management
Trinity Ventures, Ltd.
Boston Consulting Group

Academic
Dartmouth College, BA
Stanford University, MBA